StockNews.com initiated coverage on shares of IRIDEX (NASDAQ:IRIX – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the medical equipment provider’s stock.
IRIDEX Stock Performance
NASDAQ:IRIX opened at $1.52 on Thursday. The stock has a market cap of $24.70 million, a price-to-earnings ratio of -2.30 and a beta of 0.78. IRIDEX has a one year low of $1.45 and a one year high of $3.65. The business’s 50-day simple moving average is $1.82 and its 200 day simple moving average is $2.20.
IRIDEX (NASDAQ:IRIX – Get Free Report) last released its earnings results on Thursday, August 8th. The medical equipment provider reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.04). The business had revenue of $12.63 million for the quarter, compared to analysts’ expectations of $12.80 million. IRIDEX had a negative net margin of 21.84% and a negative return on equity of 134.37%. During the same quarter last year, the company posted ($0.17) earnings per share. On average, equities research analysts predict that IRIDEX will post -0.52 EPS for the current year.
Hedge Funds Weigh In On IRIDEX
IRIDEX Company Profile
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Recommended Stories
- Five stocks we like better than IRIDEX
- Are Penny Stocks a Good Fit for Your Portfolio?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Conference Calls and Individual Investors
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.